Innova Captab Ltd
INNOVACAPInnova Captab Ltd
INNOVACAP
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 51.08 | 7.27 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.49 | 6.67 | 0.52% |
Forecast & Ratings
Detailed Forecast from 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Innova Captab Ltd is an integrated pharmaceutical company involved in manufacturing and trading drugs, offering services across R&D, manufacturing, and distribution of generic formulations and branded generics.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 356.03 | 374.62 | 412.03 | 803.41 | 935.58 | 1,093.80 | 1,189.96 | |||||||
Raw Materials | 283.41 | 291.55 | 309.06 | 612.42 | 552.46 | 582.67 | 1,003.01 | |||||||
| Power & Fuel Cost | 4.18 | 5.54 | 5.48 | 7.91 | 9.51 | 20.39 | ||||||||
| Employee Cost | 18.10 | 20.24 | 22.33 | 40.46 | 54.80 | 90.66 | ||||||||
| Selling & Administrative Expenses | 6.54 | 7.61 | 10.32 | 16.05 | 29.61 | 40.13 | ||||||||
| Operating & Other expenses | 2.79 | -2.55 | 8.99 | 27.67 | 166.36 | 193.01 | ||||||||
EBITDA | 41.01 | 52.23 | 55.85 | 98.90 | 122.84 | 166.94 | 186.95 | |||||||
| Depreciation/Amortization | 10.67 | 10.08 | 5.59 | 7.50 | 11.08 | 15.96 | 18.18 | |||||||
| PBIT | 30.34 | 42.15 | 50.26 | 91.40 | 111.76 | 150.98 | 168.77 | |||||||
| Interest & Other Items | 5.58 | 4.63 | 3.93 | 5.68 | 19.97 | 21.46 | 7.90 | |||||||
| PBT | 24.76 | 37.52 | 46.33 | 85.72 | 91.79 | 129.52 | 160.87 | |||||||
| Taxes & Other Items | 4.89 | 9.65 | 11.85 | 21.77 | 23.84 | 35.18 | 42.55 | |||||||
| Net Income | 19.87 | 27.87 | 34.48 | 63.95 | 67.95 | 94.34 | 118.32 | |||||||
| EPS | 165.58 | 11.33 | 7.18 | 24.22 | 25.74 | 17.93 | 20.68 | |||||||
| DPS | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Innova Captab Ltd | 64.07 | 7.27 | — |
| Sun Pharmaceutical Industries Ltd | 46.13 | 6.58 | 0.73% |
| Cipla Ltd | 29.21 | 4.49 | 0.87% |
| Mankind Pharma Ltd | 62.91 | 12.57 | — |
Price Comparison
Compare INNOVACAP with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Innova Captab Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Kotak Multicap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 3.2811% | Percentage of the fund’s portfolio invested in the stock 1.16% | Change in the portfolio weight of the stock over the last 3 months 0.34% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 54/72 (+2) |
Canara Robeco Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.9022% | Percentage of the fund’s portfolio invested in the stock 1.30% | Change in the portfolio weight of the stock over the last 3 months 0.45% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 16/104 (+77) |
Invesco India Midcap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.5958% | Percentage of the fund’s portfolio invested in the stock 1.52% | Change in the portfolio weight of the stock over the last 3 months 0.49% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 32/59 (+12) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
INNOVACAP has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNet profit of Innova Captab rose 52.77% to Rs 35.00 crore in the quarter ended September 2024 as against Rs 22.91 crore during the previous quarter ended September 2023. Sales rose 12.46% to Rs 318.20 crore in the quarter ended September 2024 as against Rs 282.94 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales318.20282.94 12 OPM %15.6314.31 - PBDT51.8035.01 48 PBT46.8130.18 55 NP35.0022.91 53 Powered by Capital Market - Live
Innova Captab will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live
Innova Captab announced that the 20th Annual General Meeting (AGM) of the company will be held on 18 September 2024.Powered by Capital Market - Live
Net profit of Innova Captab rose 67.60% to Rs 29.48 crore in the quarter ended June 2024 as against Rs 17.59 crore during the previous quarter ended June 2023. Sales rose 26.17% to Rs 294.27 crore in the quarter ended June 2024 as against Rs 233.24 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales294.27233.24 26 OPM %14.3313.42 - PBDT44.1627.39 61 PBT39.3124.60 60 NP29.4817.59 68 Powered by Capital Market - Live
Innova Captab will hold a meeting of the Board of Directors of the Company on 9 August 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 25.17%, vs industry avg of 9.04%
Increasing Market Share
Over the last 5 years, market share increased from 0.16% to 0.29%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 36.55%, vs industry avg of 15.28%